Algert Global’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,278
| Closed | -$131K | – | 1379 |
|
|
2022
Q1 | $131K | Buy |
2,278
+981
| +76% | +$56.4K | 0.01% | 1085 |
|
|
2021
Q4 | $154K | Sell |
1,297
-175
| -12% | -$20.8K | 0.02% | 888 |
|
|
2021
Q3 | $293K | Sell |
1,472
-188
| -11% | -$37.4K | 0.04% | 768 |
|
|
2021
Q2 | $289K | Sell |
1,660
-1,013
| -38% | -$176K | 0.1% | 293 |
|
|
2021
Q1 | $529K | Sell |
2,673
-1,475
| -36% | -$292K | 0.17% | 197 |
|
|
2020
Q4 | $816K | Sell |
4,148
-174
| -4% | -$34.2K | 0.23% | 156 |
|
|
2020
Q3 | $766K | Buy |
+4,322
| New | +$766K | 0.24% | 149 |
|
|
2019
Q4 | – | Sell |
-936
| Closed | -$180K | – | 435 |
|
|
2019
Q3 | $180K | Buy |
936
+54
| +6% | +$10.4K | 0.07% | 290 |
|
|
2019
Q2 | $151K | Buy |
882
+148
| +20% | +$25.3K | 0.06% | 300 |
|
|
2019
Q1 | $148K | Sell |
734
-293
| -29% | -$59.1K | 0.08% | 263 |
|
|
2018
Q4 | $192K | Buy |
+1,027
| New | +$192K | 0.05% | 336 |
|